The Rational Corporate Contribution Recipient

Tying together recent threads on prescription drug policy and tradE, here I see PPI's Ed Gresser (PPI is the DLC think tank) making the case that our trade policy needs to change not to become more favorable to the interests of working class Americans, but to become more favorable to the interests of movie studio executives and pharmaceutical company shareholders.

This article available online at:

http://www.theatlantic.com/politics/archive/2007/06/the-rational-corporate-contribution-recipient/42725/